Unknown

Dataset Information

0

Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond.


ABSTRACT: Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat viral diseases after solid organ or allogeneic hematopoietic cell-transplantation (allo-HCT). Since the early proof-of-principle studies demonstrating that seropositive donor-derived T cells, specific for the commonest pathogens post transplantation, namely cytomegalovirus or Epstein-Barr virus (EBV) and generated by time- and labor-intensive protocols, could effectively control viral infections, major breakthroughs have then streamlined the manufacturing process of pathogen-specific T cells (pSTs), broadened the breadth of target recognition to even include novel emerging pathogens and enabled off-the-shelf administration or pathogen-naive donor pST production. We herein review the journey of evolution of adoptive immunotherapy with nonengineered, natural pSTs against infections and virus-associated malignancies in the transplant setting and briefly touch upon recent achievements using pSTs outside this context.

SUBMITTER: Papadopoulou A 

PROVIDER: S-EPMC9831191 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond.

Papadopoulou Anastasia A   Alvanou Maria M   Karavalakis George G   Tzannou Ifigeneia I   Yannaki Evangelia E  

HemaSphere 20230109 1


Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat viral diseases after solid organ or allogeneic hematopoietic cell-transplantation (allo-HCT). Since the early proof-of-principle studies demonstrating that seropositive donor-derived T cells, specific for the commonest pathogens post transplantation, namely cytomegalovirus or Epstein-Barr virus (EBV) and generated  ...[more]

Similar Datasets

| S-EPMC4589059 | biostudies-other
| S-EPMC4534018 | biostudies-literature
| S-EPMC4359241 | biostudies-literature
| S-EPMC4760087 | biostudies-literature
| S-EPMC4033650 | biostudies-literature
| S-EPMC7846101 | biostudies-literature
| S-EPMC7797692 | biostudies-literature
| S-EPMC4148618 | biostudies-literature
| S-EPMC7132012 | biostudies-literature
| S-EPMC8855517 | biostudies-literature